SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001193125-24-100772 from Tyra Biosciences, Inc. (TYRA)

Tyra Biosciences, Inc.
Date: April 18, 2024 · CIK: 0001863127 · Accession: 0001193125-24-100772

AI Filing Summary & Sentiment

File numbers found in text: 333-278068

Date
April 18, 2024
Author
Not clearly detected
Form
CORRESP
Company
Tyra Biosciences, Inc.

Letter

Tyra Biosciences, Inc.

2656 State Street

Carlsbad, CA 92008

April 18, 2024

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Re: Tyra Biosciences, Inc.

Registration Statement on Form S-3

File No. 333-278068

To the addressees set forth above:

Pursuant to Rule 461 of Regulation C of the General Rules and Regulations under the Securities Act of 1933, as amended, the undersigned, on behalf of Tyra Biosciences, Inc., respectfully requests that the effective date of the Registration Statement on Form S-3 referred to above be accelerated so that it will become effective at 4:00 P.M. Eastern Time on April 22, 2024, or as soon as practicable thereafter.

If you have any questions or require additional information, please contact Matthew T. Bush, Esq. of Latham & Watkins LLP at (858) 523-3962. Thank you for your assistance and cooperation in this matter.

Very truly yours,
TYRA BIOSCIENCES, INC.

Show Raw Text
CORRESP
1
filename1.htm

CORRESP

 Tyra Biosciences, Inc.

2656 State Street

Carlsbad, CA 92008

 April 18, 2024

 VIA EDGAR

 U.S. Securities and Exchange
Commission

 Division of Corporation Finance

 100 F Street,
N.E.

 Washington, D.C. 20549

Re:
 Tyra Biosciences, Inc.

Registration Statement on Form S-3

File No. 333-278068

To the addressees set forth above:

 Pursuant to
Rule 461 of Regulation C of the General Rules and Regulations under the Securities Act of 1933, as amended, the undersigned, on behalf of Tyra Biosciences, Inc., respectfully requests that the effective date of the Registration Statement on Form S-3 referred to above be accelerated so that it will become effective at 4:00 P.M. Eastern Time on April 22, 2024, or as soon as practicable thereafter.

If you have any questions or require additional information, please contact Matthew T. Bush, Esq. of Latham & Watkins LLP at (858) 523-3962. Thank you for your assistance and cooperation in this matter.

Very truly yours,

TYRA BIOSCIENCES, INC.

By:

/s/ Ali Fawaz

Ali Fawaz

General Counsel

 cc: Matthew T. Bush, Latham & Watkins LLP